Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05537610 · ClinicalTrials.gov registry record · NA
Extensions of Resurgence as Choice
A NA study of Aggression and Problem Behavior, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05537610: Recruiting NA study of Aggression and Problem Behavior, sponsored by Rutgers, The State University of New Jersey.
NCT05537610 is a NA study of Aggression and Problem Behavior that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 30 participants, below the 154-participant average among 21 other Aggression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05537610, a NA study of Aggression and Problem Behavior, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Although behavioral treatments for decreasing destructive behavior, such as differential reinforcement of alternative behavior (DRA), are effective in the clinic, problem behavior often returns when a caregiver does not give the child their way in the natural environment (e.g., caregiver is busy with an infant sibling). This form of treatment relapse is known as resurgence. The goal of the current study is to evaluate whether alternating sessions in which the child can have their way (i.e., "on" sessions) with sessions in which the child can not have their way (i.e., "off" sessions) helps to mitigate resurgence.
Primary Outcome
The investigators will compare the rates of problem behavior during the first six sessions of the resurgence test across the two experimental groups.
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL CDT
Study Locations (1)
New Jersey
- Children's Specialized Hospital-Rutgers University Center for Autism Research, Education, and Services - Somerset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
What NCT05537610 shows while recruiting
NCT05537610 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 154-participant average among 21 other Aggression trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Aggression appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT05537610 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05537610 about?
NCT05537610 is a clinical study titled "Extensions of Resurgence as Choice". Although behavioral treatments for decreasing destructive behavior, such as differential reinforcement of alternative behavior (DRA), are effective in the clinic, problem behavior often returns when a caregiver does not give the child their way in the natural environment (e.g., caregiver is busy wit...
What is the current status of trial NCT05537610?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-02-01. Estimated completion is 2028-01-31.
What conditions does trial NCT05537610 study?
This clinical trial studies the following conditions: Aggression, Problem Behavior, Self-Injury.
What interventions are being tested in trial NCT05537610?
The interventions under investigation include: Control (BEHAVIORAL), CDT (BEHAVIORAL).
Who is sponsoring clinical trial NCT05537610?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05537610 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aggression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05537610's enrollment target sits among peer trials
30 17th of 21 higher than 3 of 21 other Aggression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aggression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
Manualized Assessment and Treatment Model of Challenging Behavior
RECRUITING · NA
-
Refinements of Functional Communication Training
RECRUITING · NA
-
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
RECRUITING · NA
-
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
RECRUITING · NA
-
Basic and Applied Research on Extinction Bursts
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI